Abstract |
With the advancement in the mechanism of immune surveillance and immune evasion in cancer cells, cancer immunotherapy shows promising results for treating cancer with established efficacy and less toxicity. As a result of the off-target effect, the approach for delivering vaccines, adjuvants, or antibodies directly to tumor sites is gaining widespread attention. An effective alternative is to utilize nanoengineered particles, functioning as drug-delivery systems or as antigens themselves. This article reviews the practical implementation of nanotechnology in cancer immunotherapy.
|
Authors | Yihai Liu, Xixi Wang, Mubashir Hussain, Mu Lv, Xiaohan Dong, Tianying Wang, Xueqin Xu, Bin Liu |
Journal | Medical sciences (Basel, Switzerland)
(Med Sci (Basel))
Vol. 6
Issue 4
(Nov 09 2018)
ISSN: 2076-3271 [Electronic] Switzerland |
PMID | 30424010
(Publication Type: Journal Article, Review)
|